QV
QVCGB
QVC Group, Inc.
$6.00
0.00%
No data for this timeframe.
Vol
Inst. Holders6 funds
Inst. Value$275.2K
Inst. Activity0 buys / 4 sells
SEC Reports4
Recent Activity
Apr 24, 2026
SEC
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed an amended Form 3/A to correct an overstatement in their init
3/A — Impact 2/10
Apr 23, 2026
SEC
Goldman Sachs & Co. LLC and its parent Goldman Sachs Group Inc. filed a Form 3 disclosing beneficial ownership of QVC Gr
3 — Impact 3/10
Apr 20, 2026
SEC
QVC Group, Inc. received a delisting notice from Nasdaq due to its Chapter 11 bankruptcy filing, resulting in the suspen
8-K — Impact 8/10
Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Inst.
FMR LLC — EXIT
0 shares ($0.00)
Analyst Ratings
0Strong Buy
0Buy
3Hold
2Sell
3Strong Sell
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $190.4K | EXIT |
| UBS Group AG | $46.1K | EXIT |
| FMR LLC | $13.8K | EXIT |
| BANK OF AMERICA CORP | $12.9K | EXIT |
| MORGAN STANLEY | $8.8K | TRIM |
6 institutional holders with $275.2K total value (41,450 shares) as of 2025-Q1. Top holders: VANGUARD, UBS, FMR.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 28,675 | $190.4K | 69.2% | EXIT -100.0% |
| 2 | UBS Group AG | 6,945 | $46.1K | 16.8% | EXIT -100.0% |
| 3 | FMR LLC | 2,081 | $13.8K | 5.0% | EXIT -100.0% |
| 4 | BANK OF AMERICA CORP /DE/ | 1,945 | $12.9K | 4.7% | EXIT -100.0% |
| 5 | MORGAN STANLEY | 1,326 | $8.8K | 3.2% | TRIM -70.7% |
| 6 | WELLS FARGO & COMPANY/MN | 478 | $3.2K | 1.2% | ADD +52.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | EXIT | 6,945 | 0 | -100.0% | $0.00 | 2025-Q2 |
| FMR LLC | EXIT | 2,081 | 0 | -100.0% | $0.00 | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | EXIT | 1,945 | 0 | -100.0% | $0.00 | 2025-Q2 |
| VANGUARD GROUP INC | EXIT | 28,675 | 0 | -100.0% | $0.00 | 2025-Q2 |
| VANGUARD GROUP INC | NEW | — | 28,675 | — | $190.4K | 2025-Q1 |
| UBS Group AG | TRIM | 9,615 | 6,945 | -27.8% | $46.1K | 2025-Q1 |
| FMR LLC | DOUBLED | 14 | 2,081 | +14764.3% | $13.8K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 4,526 | 1,326 | -70.7% | $8.8K | 2025-Q1 |
| UBS Group AG | DOUBLED | 398 | 9,615 | +1510.6% | $27.8K | 2024-Q4 |
| MORGAN STANLEY | ADD | 3,525 | 4,526 | +28.4% | $13.1K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 307 | 467 | +52.1% | $1.3K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 1,669 | 3,525 | +111.2% | $15.1K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 2 neutral. Avg impact: 5.5/10.
NEUTRAL
3/A
2/10
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed an amended Form 3/A to correct an oversta
Apr 24, 2026
NEUTRAL
3
3/10
Goldman Sachs & Co. LLC and its parent Goldman Sachs Group Inc. filed a Form 3 disclosing beneficial
Apr 23, 2026
BEARISH
8-K
8/10
QVC Group, Inc. received a delisting notice from Nasdaq due to its Chapter 11 bankruptcy filing, res
Apr 20, 2026
BEARISH
8-K
9/10
QVC Group, Inc. and its affiliates have filed for Chapter 11 bankruptcy with a prepackaged plan to r
Apr 17, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 8 analysts — 0 strong buy, 0 buy, 3 hold, 2 sell, 3 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Feb 1, 2025 | 0 | 0 | 3 | 2 | 3 | 0% | |
| Jan 1, 2025 | 0 | 0 | 3 | 2 | 3 | 0% | |
| Dec 1, 2024 | 0 | 0 | 3 | 2 | 3 | 0% | |
| Nov 1, 2024 | 0 | 0 | 3 | 2 | 3 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.